JNJ - Johnson & Johnson

NYSE - NYSE Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
82,729,000
82,059,000
81,581,000
76,450,000
71,890,000
Cost of revenue
28,003,000
27,556,000
27,091,000
25,354,000
21,685,000
Gross profit
54,726,000
54,503,000
54,490,000
51,096,000
50,205,000
Operating expenses
Research development
11,077,000
11,355,000
10,775,000
10,554,000
9,095,000
Selling general and administrative
22,162,000
22,178,000
22,540,000
21,420,000
19,945,000
Total operating expenses
33,239,000
33,533,000
33,315,000
31,974,000
29,040,000
Operating income or loss
21,487,000
20,970,000
21,175,000
19,122,000
21,165,000
Interest expense
241,000
318,000
1,005,000
934,000
726,000
Total other income/expenses net
-2,156,000
-3,681,000
-2,782,000
-900,000
-1,004,000
Income before tax
19,415,000
17,328,000
17,999,000
17,673,000
19,803,000
Income tax expense
2,249,000
2,209,000
2,702,000
16,373,000
3,263,000
Income from continuing operations
17,166,000
15,119,000
15,297,000
1,300,000
16,540,000
Net income
17,166,000
15,119,000
15,297,000
1,300,000
16,540,000
Net income available to common shareholders
17,166,000
15,119,000
15,297,000
1,300,000
16,540,000
Basic EPS
-
5.74
5.75
0.48
6.08
Diluted EPS
-
5.63
5.61
0.47
5.93
Basic average shares
-
2,632,507
2,662,324
2,682,525
2,706,511
Diluted average shares
-
2,684,300
2,728,700
2,745,300
2,788,900
EBITDA
-
24,655,000
25,933,000
24,249,000
24,283,000
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more